Introduction TCS are known to be at increased risk for acute and chronic medical conditions, but few studies have examined barometers of their psychological health.
Objectives
To characterize the prevalence of PSM use and associations with demographics, health behaviors, and treatment-associated toxicities among TCS.
Methods TCS aged ≤49 years at first-line CHEM completed a questionnaire regarding co-morbidities and prescription drug use, including PSMs. For co-morbidities, peripheral neuropathy (PN) responses of 'a little', "quite a bit", or "very much" were scored 'yes.' Fisher's exact test was used to examine the significance of various associations.
Results
Among the first 680 consecutively enrolled TCS, median age at TC diagnosis was 31y (range, 15-49y) and median time since CHEM completion was 52mo (range 12-360mo 
Conclusions
Future studies should aim for identification of high-risk patients in need of intensified preventive and therapeutic interventions.
